Despite advances in management and treatment, retinopathy of prematurity remains a major cause of childhood blindness. Evidence for a genetic basis for susceptibility to retinopathy of prematurity is examined, including the influences of sex, ethnicity, and ocular pigmentation. The role of polymorphisms is explored in the genes for vascular endothelial growth factor and insulin-like growth factor-1, and of mutations in the Norrie disease gene. Insights into the genetic basis of retinopathy of prematurity provided by the animal model of oxygen induced retinopathy are examined. Evidence for a genetic component for susceptibility to retinopathy of prematurity is strong, although the molecular identity of the gene or genes involved remains uncertain.
- retinopathy of prematurity
- oxygen induced retinopathy
- genetic risk factors
- molecular genetics
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Competing interests: None declared.
Cryotherapy for Retinopathy of Prematurity Cooperative Group
Early Treatment for Retinopathy of Prematurity Cooperative Group
- FEVR familial exudative vitreoretinopathy
insulin-like growth factor1
oxygen induced retinopathy
retinopathy of prematurity
vascular endothelial growth factor